Carr Financial Group Corp

Position in IBRX — ImmunityBio, Inc.

CIK 1931232 WORCESTER, MA

Position in IBRX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,814,806

-$115,180 QoQ

Shares Held

207,288

-17.6% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#75

of 401 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Carr Financial Group Corp holds $2,071,215 across 3 Biotechnology names. IBRX ranks #1 (87.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc. This page	207,288	$1,814,806
2	VRTX	Vertex Pharmaceuticals Inc / Ma	417	$207,136
3	CHRS	Coherus Oncology, Inc.	35,195	$49,273

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,814,806	207,288	-17.6%	Shares	Sole	2026-08-06
2026-03-31	$1,929,986	251,628	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.